Provention Announces Positive Data from Phase 1b Study of PRV-3279, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) March 12, 2020https://www.biospace.com/article/releases/provention-announces-positive-data-from-phase-1b-prevail-study-of-prv-3279/ Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
